Drug · DIN 02550938
PLENVU
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 30, 2026.
- Drug Identification Number (DIN)
- 02550938
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Kit; Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Macrogol, combinations A06AD65
- Class
- Human
- Record last updated
- August 11, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| POLYETHYLENE GLYCOL 3350 | 140 G | |
| SODIUM ASCORBATE | 48.11 G | |
| SODIUM SULFATE ANHYDROUS | 9 G | |
| ASCORBIC ACID | 7.54 G | |
| SODIUM CHLORIDE | 5.2 G | |
| POTASSIUM CHLORIDE | 2.2 G |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 16, 2024: NOC 33824New Drug Submission (NDS)